AI-Powered Counseling for Depression and Anxiety

(SPEAC Trial)

No longer recruiting at 1 trial location
AB
JM
Overseen ByJun Ma, MD, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Illinois at Chicago

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how coaching, either from an AI-powered virtual coach or a human coach, can improve emotional health in individuals with untreated mild-to-moderate depression and anxiety. Participants will be divided into three groups to receive problem-solving skills training through an AI coach, a human coach, or a delayed option for the AI coach. Ideal participants are those experiencing significant emotional distress from depression or anxiety but have not yet sought treatment. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance emotional health strategies for many.

Do I have to stop taking my current medications to join the trial?

Yes, you must not be on current pharmacotherapy for depression or anxiety to join the trial. However, if you start taking medications after joining, you won't be withdrawn from the study.

Do I need to stop my current medications to join the trial?

The trial requires that participants do not currently take medications for depression or anxiety. However, if you start taking these medications after joining, you won't be removed from the study.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that problem-solving treatment (PST) is generally safe for people with depression and anxiety. The Lumen Coached PST program uses a virtual voice-based coach to guide participants. Early studies with Lumen have shown promising results in improving thinking and emotional well-being without serious side effects. Participants found it helpful in managing daily challenges.

The Human Coached PST is also a well-known method. It has been used successfully to treat depression and anxiety, with no major safety concerns reported. This method involves working directly with a trained human coach, which many people find supportive and effective.

Both approaches focus on teaching problem-solving skills, which can help improve emotional well-being. While no treatment is completely risk-free, these methods are generally well-tolerated, with few negative effects reported in studies.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments because they harness the power of technology to address depression and anxiety in innovative ways. The Lumen Coached PST Intervention uses AI-driven counseling through a digital coach named Lumen, providing a unique and accessible way to learn problem-solving skills at home. This approach can offer a personalized experience with the convenience of automated reminders and flexible scheduling through a study iPad. On the other hand, the Human Coached PST Intervention combines traditional in-person sessions with remote follow-ups via Zoom, blending the familiarity of human interaction with the convenience of technology. Both methods aim to make mental health support more adaptable and accessible compared to standard therapies, which often require regular in-person visits.

What evidence suggests that this trial's treatments could be effective for depression and anxiety?

Research has shown that both Lumen Coached Problem-Solving Treatment (PST) and Human Coached PST, studied in this trial, effectively reduce symptoms of depression and anxiety. Participants may receive the Lumen AI coach, which studies have found significantly improves mood and mental control, as measured by brain scans and symptom checklists. Alternatively, participants may receive Human Coached PST, a proven and trusted treatment for these conditions, which has long been a standard method for managing depression and anxiety. Both methods in this trial teach problem-solving skills to help with daily challenges affecting emotional health.12346

Who Is on the Research Team?

Ma, Jun | Department of Medicine ...

Jun Ma, MD

Principal Investigator

University of Illinois at Chicago

Are You a Good Fit for This Trial?

Adults with mild-to-moderate, untreated depression or anxiety can join. They must score within certain ranges on the PHQ-9 and GAD-7 scales, be over 18 years old, and able to give informed consent in English. Exclusions include severe medical conditions, brain injuries or abnormalities, current heavy treatments for cancer, pregnancy or recent childbirth, other clinical trials participation that could interfere with this study's results.

Inclusion Criteria

Emotional distress defined by elevated depressive (PHQ-9 scores 10-19) and/or anxious symptoms (GAD-7 scores 10-14)
Willing and able to provide informed eConsent and HIPAA authorization

Exclusion Criteria

Unable to speak, read, or understand English for informed consent
I weigh 325 pounds or more.
I was diagnosed with cancer, other than non-melanoma skin cancer, in the last year.
See 13 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention Orientation

Participants attend an orientation session to receive training and materials for the PST program

1 week
1 visit (in-person)

Treatment

Participants complete 8 PST sessions over 12 weeks, either with Coach Lumen or a human coach

12 weeks
8 sessions (4 weekly, 4 biweekly)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments at 18 weeks

18 weeks
2 visits (in-person)

Optional Extension

Participants in the delayed Lumen Coached Group can choose to start PST sessions after the 18-week follow-up

What Are the Treatments Tested in This Trial?

Interventions

  • Human Coached PST Intervention
  • Lumen Coached PST Intervention
  • Optional (delayed) Lumen Coached PST (Waitlist control)
Trial Overview The trial is testing a virtual voice-based coach called Lumen against human coaches to deliver Problem-Solving Treatment (PST) via an iPad or videoconference/phone. Participants will learn problem-solving skills over eight sessions to help manage daily problems contributing to their emotional distress.
How Is the Trial Designed?
3Treatment groups
Active Control
Placebo Group
Group I: Group 1: Lumen Coached GroupActive Control1 Intervention
Group II: Group 2: Human Coached GroupActive Control1 Intervention
Group III: Group 3: Optional (Delayed) Lumen Coached GroupPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

Penn State University

Collaborator

Trials
380
Recruited
131,000+

Washington University School of Medicine

Collaborator

Trials
2,027
Recruited
2,353,000+

Stanford University

Collaborator

Trials
2,527
Recruited
17,430,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Published Research Related to This Trial

Chatbots can effectively support patients with anxiety and depression, serving as affordable and efficient virtual assistants, especially in areas with limited mental health resources.
Out of 42 studies reviewed, about 60% of chatbots targeted both anxiety and depression, indicating their versatility in addressing multiple mental health issues, while their role in mental health care is expected to grow.
Chatbot features for anxiety and depression: A scoping review.Ahmed, A., Hassan, A., Aziz, S., et al.[2023]
Project AFFECT aims to create an AI-based software, LyssnCBT, to automatically assess the quality of cognitive behavioral therapy (CBT) sessions, which could enhance training and supervision for therapists and improve treatment outcomes for clients.
In a planned Phase II trial involving 1,875 clients, the effectiveness of LyssnCBT will be evaluated to see if it can improve therapist skills, client outcomes, and reduce client drop-out rates, marking a significant step towards scalable quality assurance in psychotherapy.
Enhancing the quality of cognitive behavioral therapy in community mental health through artificial intelligence generated fidelity feedback (Project AFFECT): a study protocol.Creed, TA., Salama, L., Slevin, R., et al.[2023]
A computer-aided self-help clinic effectively increased the number of anxious and depressed patients treated per clinician while reducing the time each patient spent with a clinician, without compromising treatment effectiveness.
Patients showed improvement using one of four computer-aided cognitive behavior therapy (CBT) systems for various anxiety and mood disorders, highlighting the potential for these systems to enhance accessibility and reduce stigma associated with mental health treatment.
Computer-aided CBT self-help for anxiety and depressive disorders: experience of a London clinic and future directions.Gega, L., Marks, I., Mataix-Cols, D.[2022]

Citations

NCT05603923 | Study of a PST-Trained Voice-Enabled ...Participants in the human coached PST arm will serve as active treatment controls given the demonstrated efficacy of human coached PST in depression and anxiety ...
Study of a PST-trained voice-enabled artificial intelligence ...Participants in the human-coached PST group will serve as an active treatment comparison given the demonstrated efficacy of human-coached PST in depression and ...
Effects of a virtual voice-based coach delivering problem ...Lumen intervention also led to decreased HADS depression, anxiety, and overall psychological distress scores, with medium effect sizes (Cohen's d = 0.49, 0.51, ...
Association Between User Interaction and Treatment ...The pilot RCT demonstrated decreased depression and anxiety symptoms in the Lumen intervention group compared with the control group [19]. This ...
AI-Powered Counseling for Depression and Anxiety · Info ...Is the treatment 'Human Coached PST Intervention, Lumen Coached PST Intervention' a promising treatment for depression and anxiety? Yes, the treatment is ...
Association Between User Interaction and Treatment ...This study evaluated the relationships between objective and subjective user interaction measures as well as treatment response on Lumen, a novel voice-based ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security